SK Chemicals will jointly carry out development and Phase 3 clinical trial of next generation children enteritis vaccine
SK Chemicals is enlarging its position in the international market with its technology and manufacturing power in vaccine.
SK Chemicals announced on the 1st that it signed an agreement for development of a next-generation enteritis vaccines for children with the PATH(Program for Appropriate Tech...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
